On a year-on-year basis, Q2 FY26 profit grew 21.28% compared to ₹664.05 crores in Q2 FY25, whilst net sales expanded 29.88% to ₹9,654.13 crores, reflecting strong volume growth across the company's fertiliser and crop protection segments. The results underscore Coromandel's ability to capitalise on improved farm economics and government support for the agriculture sector, even as the stock faces valuation headwinds in a volatile market environment.
The September quarter results represent a significant inflection point for Coromandel, which had witnessed sequential profit decline in Q1 FY26. The company's ability to deliver such strong sequential growth demonstrates the seasonal nature of the fertiliser business and management's operational prowess in navigating input cost fluctuations and distribution challenges. With the kharif season delivering better-than-expected outcomes and rabi preparations underway, Coromandel appears well-positioned to sustain this momentum through the remainder of FY26.
| Quarter | Net Sales (₹ Cr) | QoQ Growth | Net Profit (₹ Cr) | QoQ Growth | PAT Margin |
|---|---|---|---|---|---|
| Sep'25 | 9,654.13 | +37.09% | 805.33 | +59.47% | 8.22% |
| Jun'25 | 7,042.30 | +41.17% | 505.01 | -12.88% | 7.12% |
| Mar'25 | 4,988.39 | -28.07% | 579.67 | +13.27% | 11.60% |
| Dec'24 | 6,935.19 | -6.70% | 511.77 | -22.93% | 7.32% |
| Sep'24 | 7,432.83 | +57.18% | 664.05 | +113.54% | 8.87% |
| Jun'24 | 4,728.83 | +20.86% | 310.97 | +93.98% | 6.54% |
| Mar'24 | 3,912.72 | — | 160.31 | — | 4.19% |
Financial Performance: Margin Expansion Drives Profitability
Coromandel's Q2 FY26 financial performance reflects a combination of volume growth and improved operational efficiency. Net sales of ₹9,654.13 crores represented a 37.09% sequential increase from Q1 FY26's ₹7,042.30 crores, driven by peak kharif season demand and strong offtake across both fertiliser and crop protection segments. On a year-on-year basis, the 29.88% revenue growth significantly outpaced the industry average, highlighting Coromandel's market share gains and distribution strength.
Operating profit before depreciation, interest, tax, and other income (PBDIT excluding OI) stood at ₹1,146.52 crores in Q2 FY26, yielding an operating margin of 11.88%, up from 11.11% in Q1 FY26 and marginally below the 13.11% recorded in Q2 FY25. The sequential margin improvement of 77 basis points reflects better product mix and operating leverage benefits, though the year-on-year comparison reveals some compression due to higher raw material costs and competitive pressures in certain segments.
Profit after tax margin expanded to 8.22% in Q2 FY26 from 7.12% in the previous quarter, demonstrating improved bottom-line conversion. Other income contributed ₹116.48 crores during the quarter, up from ₹83.74 crores in Q1 FY26, reflecting treasury income and gains from investments. Interest costs rose to ₹101.79 crores from ₹67.96 crores sequentially, indicating higher working capital deployment during the peak season, whilst depreciation stood at ₹101.76 crores.
The tax rate for Q2 FY26 came in at 25.11%, consistent with the company's normalised tax rate. Employee costs increased to ₹264.82 crores from ₹225.44 crores in Q1 FY26, reflecting seasonal hiring and performance-linked compensation. Overall, the quality of earnings remains strong, with robust cash generation and healthy return ratios underscoring the fundamental strength of the business model.
Operational Excellence: Capital Efficiency Remains Best-in-Class
Coromandel's operational metrics continue to distinguish it from peers in the fertiliser sector. The company's average return on equity (ROE) of 21.78% significantly exceeds industry norms and reflects superior capital allocation and profitability. This high ROE demonstrates management's ability to generate strong returns on shareholder capital, a critical strength in a capital-intensive sector characterised by regulatory constraints and commodity price volatility.
Return on capital employed (ROCE) averaged an impressive 34.80% over the past five years, with the latest annual figure at 31.30%, underscoring the company's efficient asset utilisation and strong competitive positioning. These return metrics place Coromandel amongst the top quartile of Indian manufacturing companies and validate the premium valuation the stock commands in the market.
Balance Sheet Strength: Net Cash Position Provides Strategic Flexibility
Coromandel operates with a net cash balance sheet, with average net debt to equity at -0.33, meaning the company holds more cash than debt. This financial strength provides significant strategic flexibility for capacity expansion, acquisitions, and weathering commodity price cycles. The debt to EBITDA ratio of just 0.33 indicates negligible leverage, whilst interest coverage at 16.45 times demonstrates comfortable debt servicing capability. Shareholder funds stood at ₹11,087.83 crores as of March 2025, up from ₹9,419.90 crores a year earlier.
Fixed assets increased to ₹3,588.40 crores in FY25 from ₹2,708.93 crores in FY24, reflecting ongoing capacity expansion initiatives across manufacturing facilities. Current assets stood at ₹13,230.76 crores, supporting the working capital requirements of a business with significant seasonal fluctuations. The company's sales to capital employed ratio of 2.56 times demonstrates efficient asset turnover, though this has moderated from peak levels as the company invests in growth.
✓ Key Operational Strengths
Exceptional Capital Efficiency: ROE of 21.78% and ROCE of 34.80% place Coromandel amongst India's most efficient manufacturers, demonstrating superior profitability and asset utilisation that justify the premium valuation multiple.
Net Cash Balance Sheet: Zero net debt provides strategic flexibility for growth investments and insulates the company from interest rate volatility, a significant advantage in a cyclical sector.
Market Leadership: As the largest fertiliser company by market capitalisation with ₹66,390 crores, Coromandel enjoys distribution scale, brand recognition, and pricing power advantages over smaller competitors.
Seasonal Dynamics: Understanding the Fertiliser Business Cycle
The fertiliser industry in India exhibits pronounced seasonality aligned with the two main cropping seasons—kharif (monsoon season from June to October) and rabi (winter season from November to March). This seasonal pattern is clearly visible in Coromandel's quarterly results, with Q2 (July-September) and Q4 (January-March) typically representing peak revenue quarters, whilst Q1 and Q3 are relatively subdued.
The strong Q2 FY26 performance reflects robust kharif season demand, supported by above-normal monsoon rainfall across most agricultural regions. Government policies supporting minimum support prices for key crops and continued emphasis on food security have provided tailwinds for fertiliser consumption. However, subsidy payment delays and raw material price volatility remain perennial challenges that management must navigate.
Looking ahead to Q3 FY26, the company faces a seasonally weaker quarter before the rabi season picks up momentum in Q4. Investor focus will be on inventory management, subsidy realisation timelines, and early indicators of rabi season demand. The company's integrated business model—spanning fertilisers, crop protection, and speciality nutrients—provides some diversification benefits and helps smooth out seasonal volatility.
| Company | P/E (TTM) | P/BV | ROE (%) | Div Yield (%) | Mkt Cap (₹ Cr) |
|---|---|---|---|---|---|
| Coromandel Inter | 33.46 | 5.99 | 21.78 | 0.67 | 66,390 |
| F A C T | 723.58 | 42.78 | 36.14 | 0.02 | — |
| Chambal Fert. | 11.35 | 2.28 | 20.16 | 2.02 | — |
| EID Parry | 24.85 | 2.44 | 12.82 | — | — |
| Deepak Fertilis. | 19.34 | 3.04 | 15.90 | 0.67 | — |
| Paradeep Phosph. | 17.42 | 3.43 | 10.73 | 0.58 | — |
Coromandel's peer comparison reveals its premium positioning within the fertiliser sector. At a P/E ratio of 33.46 times, the stock trades at a significant premium to most peers (excluding the outlier FACT), reflecting its superior return profile, market leadership, and growth prospects. The company's ROE of 21.78% is amongst the highest in the peer group, justifying the valuation premium to some extent.
However, the price-to-book ratio of 5.99 times is notably higher than peers like Chambal Fertilisers (2.28x) and EID Parry (2.44x), suggesting that much of the positive outlook is already reflected in the current price. The dividend yield of 0.67% is modest, with the company retaining most earnings for growth investments, as evidenced by the 21.38% dividend payout ratio.
Valuation Analysis: Premium Pricing Limits Upside Potential
Coromandel's valuation metrics paint a picture of a high-quality company trading at stretched multiples. At ₹2,172.95, the stock trades at 33.46 times trailing twelve-month earnings, well above the fertiliser industry average P/E of 9 times and significantly higher than the broader market. The EV/EBITDA multiple of 21.64 times and EV/EBIT of 24.56 times similarly indicate premium pricing.
The valuation grade has been classified as "Very Expensive" since June 2024, with the stock having appreciated substantially from its 52-week low of ₹1,570.55. Currently trading 20.11% below its 52-week high of ₹2,720.00, the stock has delivered impressive long-term returns—32.57% over one year, 108.68% over two years, and 122.97% over three years—consistently outperforming the Sensex by wide margins.
The PEG ratio of 0.93 suggests that despite the high P/E multiple, the valuation is not entirely disconnected from growth prospects, with the company's 13.17% five-year sales CAGR and operational improvements supporting the premium. However, with limited margin expansion potential in a regulated sector and commodity price headwinds, the risk-reward equation appears balanced rather than compelling at current levels.
Based on normalised earnings and peer multiples, a fair value estimate for Coromandel would be in the range of ₹2,000-2,200, suggesting the stock is trading close to fair value with limited near-term upside. Investors seeking entry would be better served waiting for a meaningful correction towards ₹1,900-2,000 levels, which would offer a more attractive risk-reward profile.
Shareholding Pattern: Promoter Stake Normalises After Technical Adjustments
Coromandel's shareholding pattern has witnessed significant technical changes over recent quarters. Promoter holding stood at 56.88% as of September 2025, a dramatic increase from the 0.01% reported in June 2025. This apparent volatility is likely due to reclassification or technical adjustments in shareholding disclosures, as E.I.D. Parry (India) Limited holds 56.10% of the company as the primary promoter entity, part of the Murugappa Group.
| Shareholder Category | Sep'25 | Jun'25 | Mar'25 | QoQ Change |
|---|---|---|---|---|
| Promoter | 56.88% | 0.01% | 56.96% | +56.87% |
| FII | 14.45% | 14.29% | 10.61% | +0.16% |
| Mutual Funds | 13.06% | 13.12% | 14.98% | -0.06% |
| Insurance | 2.03% | 1.97% | 3.26% | +0.06% |
| Other DII | 0.79% | 0.78% | 0.74% | +0.01% |
| Non-Institutional | 12.79% | 12.95% | 13.45% | -0.16% |
Foreign institutional investor (FII) holding has shown steady improvement, rising from 10.61% in March 2025 to 14.45% in September 2025, indicating growing international investor confidence in the company's prospects. The sequential increase of 0.16% in Q2 FY26 suggests continued accumulation by global funds attracted to India's agriculture growth story.
Mutual fund holding declined marginally to 13.06% from 13.12% in the previous quarter, though this remains healthy institutional participation. The broader trend shows domestic mutual funds reducing stake from 14.98% in March 2025, possibly reflecting profit-booking at elevated valuations. Insurance company holdings at 2.03% represent modest participation from this investor category.
Overall institutional holding stands at 30.33%, providing a stable shareholder base. Importantly, there is zero promoter pledging, eliminating concerns about financial stress or governance issues. The Murugappa Group's continued majority stake demonstrates long-term commitment to the business, whilst the absence of pledged shares enhances corporate governance comfort for investors.
Stock Performance: Long-Term Wealth Creator Despite Recent Volatility
Coromandel's stock price performance presents a tale of two narratives—exceptional long-term wealth creation juxtaposed with recent near-term weakness. Trading at ₹2,172.95 on October 30, 2025, the stock has delivered remarkable returns across extended timeframes: 32.57% over one year, 108.68% over two years, and an astounding 1,060.76% over ten years, vastly outperforming the Sensex across all periods.
| Period | Stock Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Week | +0.45% | -0.18% | +0.63% |
| 1 Month | -4.07% | +5.15% | -9.22% |
| 3 Month | -18.06% | +3.59% | -21.65% |
| 6 Month | -1.81% | +5.19% | -7.00% |
| YTD | +15.58% | +8.02% | +7.56% |
| 1 Year | +32.57% | +5.58% | +26.99% |
| 3 Years | +122.97% | +40.77% | +82.20% |
| 5 Years | +198.77% | +113.07% | +85.70% |
However, recent performance has been challenged, with the stock declining 4.07% over one month and 18.06% over three months, significantly underperforming the Sensex during this period. The three-month negative alpha of -21.65% reflects investor concerns about elevated valuations and near-term earnings growth sustainability. Year-to-date, the stock is up 15.58%, still outperforming the Sensex's 8.02% gain.
Technical indicators present a mixed picture. The stock is currently in a "Mildly Bullish" trend since August 12, 2025, having moderated from a stronger "Bullish" classification. It trades below all key moving averages—5-day, 20-day, 50-day, 100-day, and 200-day—suggesting short-term weakness. The 20-day moving average at ₹2,225.93 represents immediate resistance, whilst the 52-week low of ₹1,570.55 provides strong support.
With a beta of 1.20, Coromandel exhibits higher volatility than the broader market, classified as a "High Beta Stock". The stock's volatility of 34.91% over the past year significantly exceeds the Sensex volatility of 12.49%, making it suitable primarily for investors with higher risk tolerance. The risk-adjusted return of 0.93 indicates positive performance after accounting for volatility, though this has moderated from peak levels.
Investment Thesis: Quality Company at Full Valuation
Coromandel International presents a compelling long-term investment case built on several enduring strengths. As India's largest fertiliser company by market capitalisation, it benefits from scale advantages, established distribution networks, and strong brand equity across rural markets. The company's integrated business model spanning fertilisers, crop protection chemicals, and speciality nutrients provides diversification benefits and cross-selling opportunities.
The fundamental quality of the business is evident in its financial metrics. An average ROE of 21.78% and ROCE of 34.80% place Coromandel amongst India's most efficient capital allocators, demonstrating the company's ability to generate superior returns in a traditionally low-margin, capital-intensive sector. The net cash balance sheet with negative net debt-to-equity of -0.33 provides strategic flexibility for growth investments and insulates the company from interest rate volatility.
Long-term structural tailwinds support the investment thesis. India's agriculture sector remains underpenetrated in terms of fertiliser intensity compared to global standards, whilst government focus on food security and farmer welfare ensures policy support. Rising farm incomes, crop diversification, and increasing adoption of speciality nutrients and crop protection products offer growth avenues beyond traditional fertilisers.
However, several factors temper enthusiasm at current valuations. The stock's classification as "Very Expensive" reflects stretched multiples, with the P/E ratio of 33.46 times significantly above industry averages and historical norms. Near-term earnings growth faces headwinds from commodity price volatility, subsidy payment delays, and margin pressures. The recent three-month price decline of 18.06% suggests the market is reassessing growth expectations.
✅ Key Strengths
- Market Leadership: Largest fertiliser company by market cap with established distribution and brand strength
- Exceptional ROE: 21.78% average return on equity demonstrates superior capital efficiency and profitability
- Net Cash Position: Negative net debt provides strategic flexibility and financial resilience
- Integrated Model: Diversification across fertilisers, crop protection, and speciality nutrients reduces concentration risk
- Strong Q2 Performance: 59% QoQ profit growth demonstrates operational leverage and seasonal strength
- Institutional Confidence: 30.33% institutional holding with rising FII stake signals investor conviction
- Long-Term Track Record: 1,060% ten-year return demonstrates consistent wealth creation capability
⚠️ Key Concerns
- Stretched Valuation: P/E of 33x and "Very Expensive" classification limits upside potential
- Recent Underperformance: 18% decline over three months with negative alpha vs Sensex
- Commodity Price Risk: Input cost volatility can compress margins unpredictably
- Subsidy Dependency: Government subsidy payment delays impact working capital and cash flows
- High Volatility: Beta of 1.20 and 34.91% volatility make it unsuitable for conservative investors
- Seasonal Business: Pronounced quarterly fluctuations complicate earnings visibility
- Limited Dividend Yield: 0.67% yield provides minimal income for dividend-focused investors
Outlook: What to Watch in Coming Quarters
The outlook for Coromandel over the next 6-12 months depends on several critical factors. The rabi season performance will be crucial, with early indicators of crop sowing, government support prices, and water reservoir levels providing clues about demand trajectory. Management's ability to navigate raw material price volatility—particularly phosphoric acid and ammonia—will determine margin sustainability.
Subsidy realisation timelines remain a key monitoring point, as delays can strain working capital despite the company's strong balance sheet. The government's budget allocation for fertiliser subsidies and any policy changes around nutrient-based subsidy schemes will have direct implications for industry dynamics and company profitability.
Positive Catalysts
- Strong Rabi Season: Favourable winter crop outlook could drive Q4 FY26 performance
- Margin Expansion: Operating leverage from volume growth and product mix improvement
- Capacity Additions: New manufacturing facilities coming onstream to capture market share
- Valuation Correction: Any meaningful price decline towards ₹1,900-2,000 improves entry point
- Policy Support: Government initiatives supporting agriculture and farmer incomes
Red Flags to Monitor
- Subsidy Delays: Extended payment cycles straining working capital and cash flows
- Raw Material Spikes: Sharp increases in phosphoric acid or ammonia prices compressing margins
- Weak Monsoon: Below-normal rainfall impacting kharif demand in future seasons
- Competitive Intensity: Aggressive pricing by peers eroding market share or margins
- Valuation De-rating: Further multiple compression if growth disappoints expectations
From a technical perspective, the stock needs to reclaim the 20-day moving average at ₹2,225.93 to resume its upward trajectory. A sustained move above ₹2,320 (100-day MA) would signal renewed strength, whilst a break below ₹2,000 could trigger further selling pressure. Delivery volumes have shown improvement, with recent delivery percentage at 50.03%, suggesting some accumulation by long-term investors.
The broader market environment will also play a role. With the Sensex having rallied strongly in recent months, any correction in benchmark indices could disproportionately impact high-beta stocks like Coromandel. Conversely, sustained economic growth, rising rural incomes, and policy continuity would support the agriculture sector and fertiliser demand.
The Verdict: Quality Franchise, But Wait for Better Entry
Score: 71/100
For Fresh Investors: Coromandel represents an excellent long-term franchise with market leadership, strong return ratios, and structural growth tailwinds. However, current valuations at 33x P/E and classification as "Very Expensive" suggest limited near-term upside. Fresh investors should consider accumulating on dips towards ₹1,900-2,000 levels, which would offer a more attractive risk-reward profile. The recent 18% correction from peaks provides some comfort, but further patience is warranted.
For Existing Holders: Continue holding with a long-term perspective. The company's operational excellence, net cash position, and market leadership justify maintaining exposure despite stretched valuations. Consider booking partial profits if the stock rallies back towards ₹2,400-2,500 to rebalance portfolio risk. The Q2 results demonstrate the business remains fundamentally strong, supporting a hold stance for those already invested.
Fair Value Estimate: ₹2,000-2,200 (8% downside to 1% upside from current levels)
Rationale: Coromandel's BUY rating reflects its exceptional quality credentials—market leadership, 21.78% ROE, net cash balance sheet, and consistent operational excellence. The strong Q2 FY26 results with 59% QoQ profit growth validate the business model's resilience. However, the "Very Expensive" valuation grade and recent underperformance temper enthusiasm, making this a "Buy on Dips" rather than "Buy at Any Price" opportunity. The investment thesis rests on long-term structural growth in Indian agriculture, but near-term returns may be modest given current multiples.
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions.
